Employers & Consultants

06.3.26

New direct-to-patient prescription models are emerging as consumers demand the same convenience, transparency, and digital control they experience…

Redmond, WA – May 6, 2026 – Prescryptive Health today announced it serves as a technology platform helping to…

“A huge challenge for healthcare leaders is that they are being asked to sustain high performance inside systems…

Will GLP-1 pills change how employers approach coverage? It’s an important question, but the answer isn't so straightforward.

On the surface, lower GLP-1 prices should make these therapies easier to manage. But as Rae McMahan, SVP…

03.13.26

Welcome to a direct access marketplace, where incentives are aligned by design so access becomes the default outcome.

Even with increased availability, access to GLP-1 therapies can be challenging for employers and healthcare consumers due to…

Access is the new standard – and with partners like Ilant Health, Prescryptive is delivering it. Our collaboration…

Redmond, WA – Friday, Jan. 9, 2026 — Prescryptive and Ilant Health today announced a collaboration to help…

12.10.25

For decades, the U.S. drug distribution model has depended on a complex web of intermediaries — pharmacy benefit…

As Seen In: Drug Topics

Prescription drug costs are among the fastest-growing and most unpredictable healthcare expenses employers face. According to recent data,…

Glucagon-like peptide-1 (GLP-1) therapies are reshaping care for diabetes, obesity, and cardiometabolic health. Yet with their rapid rise…